Dr Davuluri Rama Mohan Rao
Dr Rao is the Chief Promoter of Neuland. He has a master’s in science from Andhra University, postgraduate diploma in technology from IIT Kharagpur and a PhD in organic chemistry from the University of Notre Dame, USA. Prior to founding Neuland in 1984, he held senior positions in R&D, production and quality assurance at Glaxo India and was Director, R&D and QA at another pharmaceutical company. He is a member of the Royal Society of Chemistry.
Davuluri Sucheth Rao
Sucheth is the Vice Chairman of the Board and Chief Executive Officer of Neuland Labs, a leading manufacturer of Active Pharmaceuticals for both generic and patented New Chemical Entities. He firmly believes that his role as a leader extends beyond the organisational realm; it's about inspiring unwavering trust within the team and empowering them to unlock their full potential.
As a member of the founding family, Sucheth’ s overarching vision for Neuland, has been a relentless pursuit of transforming Neuland into one characterised by focusing on quality of business and products that empower progress and enrich lives. Central to this endeavour is the commitment to doing business as a force for good, truly sustainable, and responsible to deliver lasting financial and societal impact.
Sucheth is the Executive member of the YPO, Hyderabad Chapter. He is responsible for working with a highly capable group of CEOs/Heads of companies to improve the overall health, integration, education, and engagement of the chapter.
Sucheth has a degree in Mechanical Engineering and is an alumnus of the University of Notre Dame Mendoza College of Business in Indiana, USA, where he pursued an MBA in corporate finance and operations management. A proficiency in Six Sigma Black Belt, Sucheth leverages operational excellence to strategically expand and fortify Neuland's presence, operating in a market as rigorously regulated as the aviation industry.
Davuluri Saharsh Rao
Saharsh is an electrical engineering graduate and obtained his master’s in management information systems from Weatherhead School of Management, Cleveland, Ohio, USA. He also secured Master of Business Administration from University of North Carolina, USA. He has worked in the past with Sify Limited in various roles in the Sales organization. He joined Neuland in 2007, with responsibility for initiating the Custom Manufacturing Solutions (CMS) business. He is currently responsible for all marketing, information technology (IT), and business development activities along with oversight of R&D.
Dr Christopher M. Cimarusti
Dr Cimarusti has a PhD in Organic Chemistry from Purdue University, USA and completed his Postdoctoral Research at Columbia University, USA. He has more than 40 years of experience in the field of drug discovery, development, and manufacturing, been awarded more than 60 patents and published more than 40 papers in referred journals. Dr. Cimarusti held executive leadership positions at Squibb Corporation and Bristol-Myers Squibb (BMS) in discovery and development. His last position with BMS was as Senior Vice President, Pharmaceutical Development Centre of Excellence.
Nirmala Murthy
Ms Murthy is honorary president of the Foundation for Research in Health System, a non-government research organization, which she helped create in 1989. She has a Master’s degree in statistics from Bombay University, India (1967), and a doctorate from the Harvard School of Public Health, Boston, USA (1974). In 1974, she joined the faculty of the Indian Institute of Management, Ahmedabad, doing research and training in public health management.
Homi Rustam Khusrokhan
Mr Khusrokhan is a Fellow of the Institute of Chartered Accountants of India. He studied at the Sydenham College of Commerce & Economics and obtained a B. Com (honours) from the University of Mumbai and later at the London School of Economics and Political Science where he obtained the degree of MSc (Econ.) London. Mr. Khusrokhan has over 40 years’ experience in the corporate sector and a wide experience and knowledge of modern management techniques. He has experience and expertise in pharmaceuticals, agriculture related businesses, international business, and mergers & acquisitions.
Prasad Raghava Menon
Mr Menon is a chemical engineer from the Indian Institute of Technology (IIT), Kharagpur, India. Mr. Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry.
After a 20 years stint with chemical giant ICI, Mr. Menon went on to become Director-Technical, at Nagarjuna Fertilizers and Chemicals Limited, where he oversaw the construction and commissioning of the Company’s urea fertilizer project in Kakinada. In 2000, he took over as Managing Director of Tata Chemicals and in 2006, he stepped outside the chemicals field to become the Managing Director of Tata Power, from where he eventually retired in January 2011. After retiring from his executive role, Mr Menon continued to be a director on various Tata Boards, such as Tata Chemicals, Tata Projects (Chairman), Vistara (Chairman), Tata Consulting Engineers (Chairman), Tata Quality Management Services (Chairman), Group Sustainability and Safety Council (Chairman) till 2016. He has also served on various Boards as Independent Director - Axis Bank, SKF India, Sanmar Group, Singapore Tourism Board, Grantham Research Centre for Climate Change London, TERI. Mr Menon is a director on the Boards of - Data Patterns (India) Limited and Chemplast Sanmar. Mr. Menon is also on the Boards of Wildlife Trust of India (Chairman), Centre for Environment Education, and Kaivalyadham Yoga Institute.
Sugata Sircar
Mr Sircar is a Fellow of the Institute of Chartered Accountants of India and has completed a Global Advanced Management Program at ISB Kellogg School, India/US. He has also completed a Business Leaders Program from Harvard Business School. Mr. Sircar has over 32 years of experience in energy & automation, chemicals, textiles, tyres, FMCG and city gas distribution. He is the Executive Director and Group CFO of Azure Power Global Ltd. He has served as Chief Financial Officer (CFO) at Schneider Electric India for over 7 years. He has been the Managing Director at Gujarat Gas, the largest listed city gas distribution company in India (a subsidiary of BG Group of UK) and prior to that was Finance Director & CFO at Gujarat Gas. He has also worked with companies like Cabot India, Madura Coats, Britannia Industries and Dunlop India in various finance roles. Mr Sircar is a business advisor, speaker, and writer. He is on the Executive Committee of the CFO Board (India's preeminent body of financial leaders) and is Ex Chairman, CFO Committee, Indo French Chamber of Commerce & Industry.
Pallavi Joshi Bakhru
Ms Bakhru, is a Fellow of the Institute of Chartered Accountants of India and Member of the Indian Institute of Corporate Affairs. She is Head of the Private Client Service offering at Grant Thornton in India. She has over 30 years of experience spanning solutions and clients in different sectors. She was Head of Tax at a large natural resources group for five years and assisted with growth strategies. In 2015, Pallavi was recognized as one of the Top 10 Women in Tax in India by the International Tax Review. Her specialties include corporate tax, litigation, including being part of a team that ran an international arbitration under Bilateral Investment Treaty (BIT), tax structuring and regulatory matters pertaining to FEMA. Over the years, she has simplified the global structure of some large groups, institutionalized a royalty payment system, resolved some high-pitched tax litigation and done Advocacy. She works closely with Promoters and CXO’s on critical aspects of business, including decisions related to business restructuring, choice of senior counsels for representation in key litigation. She has helped in re-organizing businesses and taking their geographic footprint overseas.
Dr Davuluri Rama Mohan Rao
Dr Rao is the Chief Promoter of Neuland. He has a master’s in science from Andhra University, postgraduate diploma in technology from IIT Kharagpur and a PhD in organic chemistry from the University of Notre Dame, USA. Prior to founding Neuland in 1984, he held senior positions in R&D, production and quality assurance at Glaxo India and was Director, R&D and QA at another pharmaceutical company. He is a member of the Royal Society of Chemistry.
Dr Christopher M. Cimarusti
Dr Cimarusti has a PhD in Organic Chemistry from Purdue University, USA and completed his Postdoctoral Research at Columbia University, USA. He has more than 40 years of experience in the field of drug discovery, development, and manufacturing, been awarded more than 60 patents and published more than 40 papers in referred journals. Dr. Cimarusti held executive leadership positions at Squibb Corporation and Bristol-Myers Squibb (BMS) in discovery and development. His last position with BMS was as Senior Vice President, Pharmaceutical Development Centre of Excellence.
Dr Mauricio Futran
Dr Mauricio Futran was the VP of Advanced Technology in the global tech services group of Janssen supply chain at J&J. Before joining J&J, Dr Futran was professor and chair of chemical and biochemical engineering at Rutgers University, after working for 28 years in product and process development at Merck and Co. and Bristol-Myers Squibb, where he was Vice President of Process R&D. Dr Futran has chemical engineering degrees from Rice University and Princeton University.
Dr Pushpa D. Singh
Dr Singh is a pharmaceutical R&D executive with experience in all phases of product development including discovery, development, technology transfer, and product life-cycle management. She has extensive experience in leading the creation, operation and improvement of a business area or process in the chemistry, manufacturing, and controls (CMC) arena. Dr Singh is experienced in the preparation of the CMC section of global investigational (IND/CTA), registrational (NDA/MAA/BLA) and LCM submissions for small molecules and biologics. She has a proven record of successful regulatory agency interactions such as end-of-phase 2 and pre-NDA meetings with the FDA, and regulatory agency inspections. Dr Singh has an in-depth knowledge of drug development processes, cGMP regulations, and CMC-related FDA and international regulations. She has a proven record of disciplined and logical approaches to problem solving, the ability to build new groups and capability, and extensive experience in leading and directing cross-functional teams to accomplish breakthrough results.  Dr Singh has led interdisciplinary exploratory development teams responsible for the strategy and execution of clinical and pre-clinical development plans leading to clinical proof-of-concept.
Dr Sharadsrikar Kotturi
Dr Kotturi is an innovation specialist with 20 years of diverse research experience.  Prior to joining Neuland, Dr Kotturi was Senior Vice President Operations at Piramal Pharma Ltd, where he defined the vision, formulated the strategy and implemented the metrics for a successful PDS organization, developed an ecosystem for driving innovation and was responsible for the small molecule discovery and the peptides businesses. Dr Kotturi earned his BSc (Tech), MSc (Tech) degrees from UDCT, Bombay and PhD from Oklahoma State University in 1995, 1998 and 2002 respectively and completed his postdoctoral research in medicinal chemistry at the Research Triangle Institute, North Carolina, researching newer cures for addiction. With over 20 years of experience within the pharmaceutical services industry, Dr Kotturi has authored more than 35 patents, and research articles in peer reviewed international journals. After beginning his career in research with RTI International, Dr Kotturi moved to India in 2010 and has worked in various operational and commercial roles with increasing responsibility at GVK-Bio, Tata Advinus and Piramal.
Dr Davuluri Rama Mohan Rao
Dr Rao is the Chief Promoter of Neuland. He has a master’s in science from Andhra University, postgraduate diploma in technology from IIT Kharagpur and a PhD in organic chemistry from the University of Notre Dame, USA. Prior to founding Neuland in 1984, he held senior positions in R&D, production and quality assurance at Glaxo India and was Director, R&D and QA at another pharmaceutical company. He is a member of the Royal Society of Chemistry.
Davuluri Sucheth Rao
Sucheth is the Vice- Chairman of the Board and Chief Executive Officer of Neuland Labs, a leading manufacturer of Active Pharmaceuticals for both generic and patented New Chemical Entities. He firmly believes that his role as a leader extends beyond the organisational realm; it's about inspiring unwavering trust within the team and empowering them to unlock their full potential.
As a member of the founding family, Sucheth’ s overarching vision for Neuland, has been a relentless pursuit of transforming Neuland into one characterised by focusing on quality of business and products that empower progress and enrich lives. Central to this endeavour is the commitment to doing business as a force for good, truly sustainable, and responsible to deliver lasting financial and societal impact.
Sucheth is the Executive member of the YPO, Hyderabad Chapter. He is responsible for working with a highly capable group of CEOs/Heads of companies to improve the overall health, integration, education, and engagement of the chapter.
Sucheth has a degree in Mechanical Engineering and is an alumnus of the University of Notre Dame Mendoza College of Business in Indiana, USA, where he pursued an MBA in corporate finance and operations management. A proficiency in Six Sigma Black Belt, Sucheth leverages operational excellence to strategically expand and fortify Neuland's presence, operating in a market as rigorously regulated as the aviation industry.
Davuluri Saharsh Rao
Saharsh is an electrical engineering graduate and obtained his master’s in management information systems from Weatherhead School of Management, Cleveland, Ohio, USA. He also secured Master of Business Administration from University of North Carolina, USA. He has worked in the past with Sify Limited in various roles in the Sales organization. He joined Neuland in 2007, with responsibility for initiating the Custom Manufacturing Solutions (CMS) business. He is currently responsible for all marketing, information technology (IT), and business development activities along with oversight of R&D.
Dr Sharadsrikar Kotturi
Dr Kotturi is an innovation specialist with 20 years of diverse research experience.  Prior to joining Neuland, Dr Kotturi was Senior Vice President Operations at Piramal Pharma Ltd, where he defined the vision, formulated the strategy, and implemented the metrics for a successful PDS organization, developed an ecosystem for driving innovation and was responsible for the small molecule discovery and the peptides businesses. Dr Kotturi earned his BSc (Tech), MSc (Tech) degrees from UDCT, Bombay and PhD from Oklahoma State University in 1995, 1998 and 2002 respectively and completed his postdoctoral research in medicinal chemistry at the Research Triangle Institute, North Carolina, researching newer cures for addiction. With over 20 years of experience within the pharmaceutical services industry, Dr Kotturi has authored more than 35 patents, and research articles in peer reviewed international journals. After beginning his career in research with RTI International, Dr Kotturi moved to India in 2010 and has worked in various operational and commercial roles with increasing responsibility at GVK-Bio, Tata Advinus and Piramal.    
Sudheer Yarabolu
Mr Yarabolu joined Neuland in 2000 as General Manager, Sales and Business Development. He currently spearheads the Generics Drug Substance (GDS) business as Senior Vice President, Global Sales and Business Development. He has been steering the GDS business for over two decades and is instrumental in the overall growth and strategy of the business. Mr Yarabolu’s leadership is marked by a strategic vision, a relentless drive for excellence, and a passion for fostering strong client relationships, making him a driving force behind Neuland’s continued success. Mr Yarabolu holds a bachelor’s degree in commerce, complemented by a master’s in business administration and a postgraduate diploma in Industrial Relations and Personnel Management. 
Srinivas Reddy Mothey
Mr. Srinivas Reddy Mothey is the Senior Vice President, Production at Neuland Labs. He has over 33+ years of experience in manufacturing operations. In his current role at Neuland, he oversees production, planning & delivery, EHS, technical services, projects and plant engineering. Since joining Neuland in Apr’ 2016, he has played a pivotal role in creating capacities, enhancing operational excellence, improving solvent recovery and fostering a safety and quality culture. Mr. Srinivas Reddy is a chemical engineering graduate from RV College of Engineering, Bangalore and holds certifications in Six Sigma-Black Belt and Lean-TPM. Previously, he led CMS manufacturing, technology transfer & site operational excellence significantly contributing to capacity enhancement of various CMS products, solvent recovery establishments and improving OTIF.
Ashutosh Kumar Sinha
Mr Sinha is the Chief Quality Officer at Neuland, with 28+ years of experience in the pharma industry. He oversees the quality system design, development, and maintenance to meet regulatory and customer expectations. He joined Neuland in March 2024, after working at Syngene International Limited, where he led several quality improvement projects and ensured audit readiness. Before that, he held various quality leadership roles at Dr Reddy’s Lab, Symbiotec Pharma, Glenmark Generics, and Ranbaxy Labs. He has a master’s in total quality management and a post-graduation in pharmaceutical chemistry. He has been recognized for his outstanding performance at Glenmark Generics Ltd., Ranbaxy, and Dr Reddy’s.
Sundar Narsimhan
Mr Narsimhan is the Chief Procurement Officer at Neuland. In his role he is responsible for planning & procurement, strategic sourcing, contract manufacturing, plant warehousing, inventory management, logistics both inbound and outbound. He drives the operational excellence and supply chain processes to improve quality, bring in cost efficiency, vendor de-risking strategy, and reduction of dependency on China, from a material and geographical standpoint, to achieve multiple sources and stable supplies for all critical raw materials keeping regulatory requirements in perspective. Mr Narsimhan brings 30 plus years of experience in Procurement and supply chain and is a member of the Steering Committee that handles the growth & strategy for Neuland. Mr Narsimhan is a mechanical engineer, earned a Ph.D. from GITAM Deemed University in business, management, marketing, and related support services from 2013 – 2019; diploma from Theory of Constraints Institute in 2008; and an international advanced certificate in supply chain management, 2003; and CPM from IIMM, Mumbai in 2001 among others. He is a Life Member of Indian Institute of Materials Management, has a lifetime certification from the Institute of Supply Management, USA and is a noted speaker and coach in supply chain management.
Abhishek Mittal
Before joining Neuland, Mr Mittal was with GSK Consumer Healthcare where he oversaw and led the Strategic Risk Management for R&D in APAC and India region. Prior to that, Mr Mittal has held various leadership and management positions at Dr Reddy's Laboratories, Syngene International, and Torrent Pharmaceuticals Ltd. A PMI certified Project Management Professional (PMP®) and IRM certified enterprise risk management professional (IRMCert®), he is experienced in managing complex programs and projects, operational excellence, alliance management, business performance management, systems development, and business transformation. Mr Mittal received an MBA from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, and a BPharm from Panjab University, Chandigarh, India.
Abhijit Majumdar
Mr Majumdar is a Chief Financial Officer with over 30 years’ experience in finance, working capital management, indirect and direct tax, mergers & acquisition, and digital initiatives, handling statutory audits, Treasury and managing relations with banks, financial planning. Mr Majumdar is responsible for overseeing the finance function at Neuland and acts as a key business integrator across the company. He has worked with organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others. In his previous leadership roles, he led the HR, supply chain and commercial functions. Mr Majumdar holds a degree in chartered and cost accountancy from the Institute of Chartered Accountants, India and the Institute of Cost Account, India.
Hemchandra Peruvelli
Responsible for managing the HR function for the organization including leadership development, compensation management, talent and performance management, people policies, executive sourcing, leadership training and change management aligned with the overall organizational mandate. He has also been actively steering the company’s efforts to create a more inclusive workforce as the Chair for Diversity, Equity, and Inclusion (DEI) in India. Mr Peruvelli joined Neuland in July 2022 from HIL Limited where he was the CHRO. He was instrumental in developing and delivering the growth strategy including transformation of the organization from being a national player to having a global presence across 88 countries. Over the years, he has played various leadership roles in organizations such as GSK, HSBC, Asian Paints and Alghanim Industries (Kuwait). Mr Peruvelli holds an MBA from XLRI Jamshedpur and is a commerce graduate from Hansraj College, Delhi University. He is ACC certified and is a mentor/ coach to many of the employees within the organization. He is a Rotarian and plays an active role in supporting community development initiatives.
Ajitabh Singh
A competent professional offering over 18 years’ experience in IT project leadership, digital transformation, process optimization, change management, business acumen, team development, AI/ML and ERP. He has a consistent track record of delivering successful transformation projects, managing change, and aligning technology initiatives with organization's strategic objectives. Mr Singh is responsible for overseeing the development, maintenance, and support of Information Technology and digital transformation initiatives across Neuland. Mr Singh joined Neuland in March’23. Before that he Led PI Industries’ CSM business to a successful digital journey adoption by designing and implementing strategic digital transformation plans that leveraged business enablement, reduced costs, and streamlined operations to ensure competitiveness in the market. Mr Singh has a management degree from K J Somaiya Institute of Management Studies, Mumbai. In addition, he holds prestigious certifications in project management, supply chain, Six Sigma, digital transformation, AI/ML from bodies like PMI, APICS, ISB and Google. Mr Singh is an ERP turnaround specialist leading to significant business improvements in key business operations and holds SAP certification in seven key modules.
Sajeev Medikonda
Mr Medikonda heads the Corporate Planning & Strategy for Neuland. He has 15+ years of experience in the pharma industry. Prior to joining Neuland, he has worked for Pfizer India on business cases for launch of Generic products (set up the process and framework for product selection), forecasting & product launch of Pfizer’s patented products and Business Analytics. He has worked exclusively on a project for Merck on Strategic Forecasting as well as Demand Forecasting with an Analytics Consulting firm. At Neuland, he is responsible for Corporate Strategy, Portfolio & Product Strategy, Enterprise Risk Management, and Investor Relations. He has joined Neuland in May 2013. Sajeev has a postgraduate degree in management from IIM-Indore and a PGP in Artificial Intelligence & Machine Learning.